
|Videos|September 29, 2021
Dr. Chancellor discusses novel regenerative therapy for recurrent SUI
Author(s)Urology Times staff
Advertisement
In this video, Michael B. Chancellor, MD, discusses the background, findings and takeaways of the study, “An evaluation of women with persistent or recurrent stress urinary incontinence (SUI) following surgery in a double-bling, randomized, controlled trial comparing safety and efficacy of autologous muscle derived cells for urinary sphincter repair (AMDC-USR) with placebo (PBO),” presented at the 2021 American Urological Association Annual Meeting. Chancellor is a professor and director of neurourology at Oakland University, Royal Oak, Michigan.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
CMS' 2027 PFS proposed rule: Modifier -25 cuts, G2211 overhaul loom
2
The UroOnc Minute: Cribriform Histology in Prostate Cancer, With Tyler Seibert, MD, PhD
3
Rezūm shows greater 1-year BPH symptom relief vs pharmacotherapy
4
FDA grants breakthrough therapy, fast track designations to kidney cancer imaging agent
5










